Skip to content
  • beauty

S-haematococcus lacustris OLIGOPEPTIDE-1

Concern score

Not assessed — no hazard data yet.

S-haematococcus lacustris OLIGOPEPTIDE-1 in plain language

What it does

Used in cosmetics as an emollient and a skin-conditioning agent.

  • Emollient
  • Skin conditioning
Is it a concern?
We haven't assessed a concern score for this ingredient yet. It is listed for cosmetic use in the EU.

What we know about this ingredient

Canonical ingredient record built from 1 public-source records.

Regulation

No restrictions found. S-haematococcus lacustris OLIGOPEPTIDE-1 appears in these published regulatory listings.

  • EUCosIngActives-Haematococcus Lacustris Oligopeptide-1 is a single chain peptide consisting of alanine, aspartic acid, glutamic acid, glycine, leucine, lysine, proline, tryptophan and valine. It is synthetically produced based on a sequence from Acetamidase found in Haematococcus lacustris. The parent protein contains a maximum of 146 amino acids which may contain disulfide bonds and/or glycosylation, and consists of the proper sequence from the 20 standard amino acids.
    • s-Haematococcus Lacustris Oligopeptide-1 is a single chain peptide consisting of alanine, aspartic acid, glutamic acid, glycine, leucine, lysine, proline, tryptophan and valine. It is synthetically produced based on a sequence from Acetamidase found in Haematococcus lacustris. The parent protein contains a maximum of 146 amino acids which may contain disulfide bonds and/or glycosylation, and consists of the proper sequence from the 20 standard amino acids.Source →

Expert safety opinions

No expert opinion on file for S-haematococcus lacustris OLIGOPEPTIDE-1. These are the independent scientific bodies that assess ingredients like this one; we show an opinion only when a record we hold cites it.

  • SCCS

    EU Scientific Committee on Consumer Safety

    No SCCS opinion on file.

  • CIR

    Cosmetic Ingredient Review (US expert panel)

    No CIR safety assessment on file.

Evidence & sources

No graded research studies for S-haematococcus lacustris OLIGOPEPTIDE-1 yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.

1 data source

Where this comes from

  • CosIng

    regulatory · updated 2026-09-23

    Open →

Suitability

Context-specific fit derived from published classifications and the current ingredient evidence profile.

Fragrance avoidance

Nothing to weigh for this context yet.

No signal in this context

We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.